When the bone marrow is overactive and produces an excessive number of platelets and enters the bloodstream, it will cause a number of dangerous blood-clotting disorders, increasing the risk of unwanted blood clots. Therefore, the drug Agrylin is indicated in the treatment of thrombocytopenia to help limit this condition.